首页>
中文期刊>
《中国药理学报：英文版》
>The immunoglobulin D Fc receptor expressed on fibroblast-like synoviocytes from patients with rheumatoid arthritis contributes to the cell activation
The immunoglobulin D Fc receptor expressed on fibroblast-like synoviocytes from patients with rheumatoid arthritis contributes to the cell activation
Immunoglobulin IgD might play an important role in autoimmune diseases,but the function of IgD has remained elusive,despite multiple attempts to define its biological function.Fibroblast-like synoviocytes (FLSs) are specialized cells of the synovium that play a key role in the pathogenesis of rheumatoid arthritis (RA).In this study we explored the possible roles of excessive IgD expression on the function of FLSs from RA patients (RA-FLSs).We showed that IgD Fc receptor (IgDR) was constitutively expressed on FLSs,and was significantly elevated in RA-FLSs compared with FLSs prepared from synovial tissues of healthy controls (HC-FLSs).Furthermore,IgDR was mainly detected on the cell surface and in the cytoplasm.We further detected the intrinsic binding affinity of IgD to IgDR on HC-FLSs with an equilibrium dissociation constant (KD) of 0.067 nmol/L.Incubation of RA-FLSs with IgD (1-10 μg/mL) for 48 h dosedependently promoted the expression of IgDR,and stimulated the production of inflammatory cytokines and chemokines,such as IL-1β,IL-6,monocyte chemotactic protein (MCP)-1,TNF-α and receptor activator of nuclear factor-κB ligand (RANKL),thus potentially contributing to IgD-IgDR crosslinking.Moreover,incubation with IgD (0.1-10 μg/mL) for 48 h dose-dependently enhanced viability for both HC-FLSs and RA-FLSs.Our results demonstrate that IgDR is expressed on RA-FLSs and contributes to the activation of FLSs,and suggest that IgD-IgDR is a potential novel immunotherapeutic target for the management of RA.
展开▼
